We are excited to announnce that Joshua Young will join our leadership team to lead the company’s Investor Relations, Communications and Strategy functions.
Kassandra Barbetsea27 October 2021
We are pleased to announce two key appointments to our Board of Directors that bring a combined 40 years of executive-level experience in human resources and finance. Melissa McLaughlin and Solange Glaize are the newest addition to LUMICKS Board, each offering invaluable insight that will help pave the way for…
Kassandra Barbetsea30 September 2021
LUMICKS recently held a successful live dynamic single-molecule workshop at Westlake University. Throughout the 2-day event, participants joined our scientists for lectures in which they explored different state-of-the-art single-molecule applications. Each day was also finished with a live DNA mechanics and visualization experiment using the C-Trap® Optical Tweezers – Fluorescence…
Ron Eliyahoo6 September 2021
A recent publication by Kucera et al. in Nature Communications combined TIRF assays and Optical Tweezers measurements to investigate myosin-independent actin contraction that is relevant during cytokinesis and cell division. The authors found a new mechanism showing how anillin, a non-motor actin crosslinking and scaffolding protein, substitutes for the activity…
Nelli Bossert23 August 2021
We are pleased to announce the appointment of Dr. Paul Wheeler to its leadership team, effective July 1, 2021. In the newly-created position of Chief Commercial Officer, Dr. Wheeler will lead LUMICKS aggressive commercial growth strategy by building a stronger market presence, developing highly-effective sales teams, and focusing on enhanced…
Kassandra Barbetsea17 August 2021
We're proud to announce ithe installation of a C-Trap® Optical Tweezers – Fluorescence & Label-free Microscopy system at VIB, the life sciences research institute in Flanders, Belgium. The C-Trap will support the research efforts of six VIB research groups across three Belgian universities studying processes underlying neurodegenerative disorders.
Kassandra Barbetsea28 July 2021
INmune Bio is employing the z-Movi® cell avidity analysis platform to demonstrate that the mechanism of action of the tumor-priming is the increase in NK cell:tumor cell avidity. Early data acquired by the z-Movi® support their hypothesis that increased cell avidity enhances NK cell killing of tumor cells. This allows…
Kassandra Barbetsea22 July 2021
In a recent article published in Science Advances, researchers investigated the mechanical consequences of a missense mutation within a highly conserved region, P305L, in the kinesin motor family member A1 (KIF1A). By employing a single-molecule approach using the C-Trap® as well as biochemical and genetic assays, Lam et al. found…
Nelli Bossert15 July 2021
We’re overjoyed to announce the placement of one of our most sophisticated C-Trap® systems at the newly formed Center for Optical Bio-Manipulation (COBM) at the Niels Bohr Institute, University of Copenhagen! The center is based around LUMICKS' C-Trap system, flaunting quadruple optical tweezers, 3 color confocal fluorescence microscopy, and STED…
Ron Eliyahoo13 July 2021
